Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Medicon Valley Developing R&D Capabilities, Attracting Attention

Nov. 20, 2002

By Cormac Sheridan

Medicon Valley, the transnational region spanning the greater Copenhagen area in Denmark and the Sk ne region in southern Sweden, is laying claim to global leadership in diabetes R&D capability. (BioWorld International)

Prokaria Fishing For Products In The Hot Springs Of Iceland

Nov. 20, 2002

By Cormac Sheridan

Medicon Valley Developing R&D Capabilities, Attracting Attention

Nov. 20, 2002

By Cormac Sheridan

Medicon Valley, the transnational region spanning the greater Copenhagen area in Denmark and the Sk ne region in southern Sweden, is laying claim to global leadership in diabetes R&D capability. (BioWorld International)

Medicon Valley Developing R&D Capabilities In Four Key Areas

Nov. 18, 2002

By Cormac Sheridan

Medicon Valley Developing R&D Capabilities In Four Key Areas

Nov. 18, 2002

By Cormac Sheridan

Meridian, Biotrin Call Off Merger Talks, Decline To Provide Details

Nov. 13, 2002

By Cormac Sheridan

Meridian, Biotrin Call Off Merger Talks, Decline To Provide Details

Nov. 13, 2002

By Cormac Sheridan

NeuroSearch, Boehringer Ingelheim Move Alzheimer's Drug To Phase IIb

Nov. 6, 2002

By Cormac Sheridan

Advances In Irish Biotech Efforts On Display At Meeting Next Week

Nov. 6, 2002

By Cormac Sheridan

NeuroSearch, Boehringer Ingelheim Move Alzheimer's Drug To Phase IIb

Nov. 6, 2002

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...